Stock Rich List
#9589 on the rich list of 14,452 insiders

Camille L. Bedrosian

Chief Medical Officer at Amylyx Pharmaceuticals; Director at Rhythm Pharmaceuticals; EVP and Chief Medical Officer at Ultragenyx Pharmaceutical. Based in Cambridge, Massachusetts.

$8.9M
in disclosed stock, −$156K (−1.72%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
9589th of 14,452
Companies held
3
Largest holding
AMLX, 81.8% of total
Latest SEC filing
Sep 10, 2026

What the $8.9M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Amylyx Pharmaceuticals AMLX
Common Stock
Directly278,064$26.20$7.3M81.8%Form 4, Sep 10, 2026
Rhythm Pharmaceuticals RYTM
Common Stock
Directly7,000$116.80$818K9.2%Form 4, Jun 18, 2025
Ultragenyx Pharmaceutical RARE
Common Stock
Directly46,720$17.22$805K9.0%Form 4, Mar 1, 2023

Share counts are the amounts Camille L. Bedrosian reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 10, 2026SoldAMLX7,947$32.21$256KView
Sep 10, 2026SoldAMLX2,081$33.09$69KView
Mar 2, 2026SoldAMLX6,461$14.58$94KView
Dec 1, 2025SoldAMLX6,580$14.35$94KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
9586Gregory Wong
CFO, QuinStreet. Foster City, CA
$8.9M+$103K (+1.17%)
9587Bruce P. Nolop
Director, Marsh & McLennan Companies. New York, NY
$8.9M−$34K (−0.37%)
9588Adele Louise Pentland
SVP General Counsel, Secretary, Roku. San Jose, CA
$8.9M−$115K (−1.28%)
9589Camille L. Bedrosian
Chief Medical Officer, Amylyx Pharmaceuticals. Cambridge, MA
$8.9M−$156K (−1.72%)
9590Bruce K. Baude
Chief Ops & Tech Officer, CNO Financial Group. Carmel, IN
$8.9M−$210K (−2.31%)
9591Samantha Sacks Gallagher
General Counsel and EVP, VICI Properties. New York, NY
$8.9M−$74K (−0.82%)
9592Dov S. Zakheim
Director, TTM Technologies. Santa Ana, CA
$8.9M−$185K (−2.03%)

Other Amylyx Pharmaceuticals insiders

All AMLX insiders

Questions

How much stock does Camille L. Bedrosian own?

Camille L. Bedrosian holds $8,907,395 in listed stock based on SEC filings and current prices, mostly Amylyx Pharmaceuticals (AMLX). That ranks 9589th on the Stock Rich List.

Is this Camille L. Bedrosian's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Camille L. Bedrosian last buy or sell stock?

The most recent open-market trade on file is a sale of 7,947 AMLX shares on Sep 10, 2026 at $32.21.